Targeted lung denervation in patients with moderate to severe COPD: AIRFLOW-2 crossover patient outcomes.

P. Shah (London, United Kingdom), A. Valipour (Vienna, Austria), C. Pison (Grenoble, France), C. Schumann (Kempten, Germany), P. Bonta (Amsterdam, Netherlands), R. Kessler (Strasborg, France), W. Gesierich (München, Germany), K. Darwiche (Essen, Germany), B. Lamprecht (Linz, Austria), D. Skowasch (Bonn, Germany), D. Slebos (Groningen, Netherlands)

Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology
Session: The hot and cold of interventional pulmonology
Session type: Oral Presentation
Number: 3775
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Shah (London, United Kingdom), A. Valipour (Vienna, Austria), C. Pison (Grenoble, France), C. Schumann (Kempten, Germany), P. Bonta (Amsterdam, Netherlands), R. Kessler (Strasborg, France), W. Gesierich (München, Germany), K. Darwiche (Essen, Germany), B. Lamprecht (Linz, Austria), D. Skowasch (Bonn, Germany), D. Slebos (Groningen, Netherlands). Targeted lung denervation in patients with moderate to severe COPD: AIRFLOW-2 crossover patient outcomes.. 3775

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Targeted lung denervation: interventions in moderate COPD patients
Source: International Congress 2019 – Interventional pneumology: live out of the box round two
Year: 2019


Two-year safety of targeted lung denervation in patients with moderate to severe COPD
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015

Long-term safety of bilateral targeted lung denervation in patients with COPD in a single procedure
Source: International Congress 2015 – Bronchoscopic treatment of COPD and asthma: valves, coils, thermoplastics and something more
Year: 2015


Regional differences in the treatment of patients with moderate COPD enrolled in a global clinical trial
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006


STEP-UP randomized controlled trial of vapor ablation in patients with severe emphysema: 12 month results
Source: International Congress 2016 – Endoscopic lung volume reduction I
Year: 2016

Lung function and treatment patterns of symptomatic patients with moderate COPD in the CRYSTAL study
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Maintenance of bronchodilation following tiotropium in patients with mild, moderate and severe COPD in one year clinical trials
Source: Eur Respir J 2001; 18: Suppl. 33, 331s
Year: 2001

Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma
Source: ERJ Open Res, 6 (1) 00204-2019; 10.1183/23120541.00204-2019
Year: 2020



Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013


The influence of lung volume reduction surgery on exercise in patients with COPD
Source: Eur Respir J 2004; 23: 269-274
Year: 2004



Effects of inspiratory muscle training on dyspnoea in severe COPD patients during pulmonary rehabilitation: controlled randomised trial
Source: Eur Respir J, 51 (1) 1701107; 10.1183/13993003.01107-2017
Year: 2018



Patients with severe COPD show significant improvements in dyspnea and lung function with once-daily QVA149: The BLAZE study
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013


Effects of inspiratory muscle training on dyspnea in severe COPD patients during pulmonary rehabilitation : controlled randomized trial
Source: International Congress 2017 – Exercise training and breathing exercises in chronic respiratory disease
Year: 2017



Role and distribution of infectious agents in exacerbations of moderate, severe and very severe forms of chronic obstructive lung disease: a prospective trial
Source: Eur Respir J 2006; 28: Suppl. 50, 735s
Year: 2006

Interval exercise for patients with severe COPD – randomised trial [SRCTN11611768]
Source: Annual Congress 2006 - Organisation and programmes in pulmonary rehabilitation
Year: 2006


Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

Neuromuscular electrical stimulation can improve whole-body exercise capacity and quality of life in patients with COPD: a randomized and controlled study
Source: Annual Congress 2006 - Organisation and programmes in pulmonary rehabilitation
Year: 2006


A randomised controlled trial of individualised, progressed early exercise in patients hospitalised with an acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
Source: International Congress 2015 – Latest insights in pulmonary rehabilitation and functional capacity
Year: 2015


Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial.
Source: Eur Respir J 2002; 20: 245
Year: 2002


Short-term effects of physiotherapy on ventilation inhomogeneity in cystic fibrosis patients with moderate to severe lung disease
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013